Henry Halliday (paediatrician)
Henry Halliday is a renowned paediatrician known for his significant contributions to neonatology and the treatment of premature infants. His work has been instrumental in advancing the care and outcomes for newborns with respiratory distress syndrome and other critical conditions.
Early Life and Education[edit | edit source]
Henry Halliday was born in Belfast, Northern Ireland. He pursued his medical education at Queen's University Belfast, where he earned his medical degree. Following his graduation, Halliday completed his residency in paediatrics and further specialized in neonatology.
Career[edit | edit source]
Halliday's career has been marked by his dedication to improving neonatal care. He has held various prestigious positions, including serving as a consultant neonatologist at the Royal Maternity Hospital in Belfast. His research has focused on the development and implementation of treatments for respiratory distress syndrome in premature infants, including the use of surfactant therapy.
Research and Contributions[edit | edit source]
One of Halliday's most notable contributions is his research on surfactant therapy, which has significantly reduced the mortality and morbidity associated with respiratory distress syndrome in premature infants. His work has been published in numerous peer-reviewed journals, and he has been a key figure in several clinical trials that have shaped modern neonatal care practices.
Awards and Recognition[edit | edit source]
Throughout his career, Halliday has received numerous awards and honors for his contributions to neonatology. He is a fellow of the Royal College of Paediatrics and Child Health and has been recognized by various medical societies for his pioneering work in the field.
Personal Life[edit | edit source]
Henry Halliday is married and has children. He continues to reside in Belfast, where he remains active in the medical community, mentoring young physicians and contributing to ongoing research in neonatology.
Related Pages[edit | edit source]
- Neonatology
- Respiratory distress syndrome
- Surfactant therapy
- Premature infant
- Queen's University Belfast
- Royal Maternity Hospital
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD